Enhanced Autophagy reveals vulnerability of P-gp mediated Epirubicin Resistance in Triple Negative Breast Cancer Cells

Epirubicin (EPI) is widely used for triple negative breast cancer (TNBC), but a substantial number of patients develop EPI resistance that is associated with poor outcome. The underlying mechanism for EPI resistance remains poorly understood. We have developed and characterized an EPI-resistant (EPI...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Apoptosis
Main Authors: Zhang, Li-han, Yang, Ai-jun, Wang, Min, Liu, Wei, Wang, Chen-yu, Xie, Xiao-feng, Chen, Xu, Dong, Jing-fei, Li, Min
Formato: Artigo
Idioma:Inglês
Publicado em: 2016
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4915730/
https://ncbi.nlm.nih.gov/pubmed/26767845
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s10495-016-1214-9
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados